(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.9%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.76%.
Hcw Biologics's earnings in 2026 is -$22,138,462.On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$8,840,798, with the lowest HCWB earnings forecast at -$8,494,100, and the highest HCWB earnings forecast at -$9,100,822. On average, 3 Wall Street analysts forecast HCWB's earnings for 2027 to be -$1,966,703, with the lowest HCWB earnings forecast at -$1,889,577, and the highest HCWB earnings forecast at -$2,024,547.
In 2028, HCWB is forecast to generate -$1,367,327 in earnings, with the lowest earnings forecast at -$1,313,706 and the highest earnings forecast at -$1,407,542.